Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Ngm Biopharmaceuticals Inc (NGM)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ngm Biopharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Ngm Biopharmaceuticals Inc since 2005.
The reporting company's ticker symbol is NGM. The reporting company's CIK number is 1426332.
The total value of stock buying since 2005 is $156,618,928.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-04-08||Kutzkey Tim (Other)||Buy||1,890,000||16.00||30,240,000|
|2019-04-08||Svennilson Peter (Director)||Buy||1,895,000||16.00||30,320,000|
|2019-04-08||Hooper Suzanne Sawochka (Director)||Buy||7,000||16.00||112,000|
|2019-04-08||Goeddel David V (Director)||Buy||1,875,000||16.00||30,000,000|
|2019-04-08||Merck Sharp & Dohme Corp. (10% Owner)||Buy||4,121,683||16.00||65,946,928|
Insider trading activities including stock purchases, stock sales, and option exercises of NGM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ngm Biopharmaceuticals Inc (symbol NGM, CIK number 1426332) see the Securities and Exchange Commission (SEC) website.